From marriage proposals to politics, many topics are discussed around the holiday dinner table. This year, make sure to talk with your loved ones about your family health history to help better understand your unique health risks. The holiday season is approaching. As you get together with loved ones —…...
Childhood Cancer Treatment by NFCR Partner Receives Fast Track Review and More Good News From the FDA
Oncoheroes Biosciences, a biotech focused on advancing new therapies for childhood cancer, recently announced that the Unites States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) to volasertib, one of its drugs. Volasertib is a small molecular inhibitor that has been…...
NFCR-Supported Researcher Leads Study Aiming to Understand Which Patients May Respond Best to Immunotherapy
New approach developed by Dr. Rakesh Jain and his research team identifies biomarkers that may indicate which patients will best respond to immune checkpoint blockade therapies. A research team led by NFCR-supported scientist Rakesh K. Jain, PhD, the Andrew Werk Cook Professor of Tumor Biology at Harvard Medical School and…...
Other Ways to Give Back: Donate Your Car!
‘Tis the season for generosity as the holiday season reminds many families just how fortunate they are. As generosity and good tidings fill the crisp winter air, National Foundation for Cancer Research (NFCR) reminds people across the country of an easy yet impactful way to support an important cause: vehicle…...
Applications Open for the National Foundation for Cancer Research’s Salisbury Award Competition for Entrepreneurial Translational Cancer Research
FOR IMMEDIATE RELEASE: December 3, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Corporate Outreach E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Program is Designed to Catalyze and Advance Promising Cancer Research Innovations onto a Path of Commercialization and Patient Impact ROCKVILLE, MD – The National Foundation…...
FDA Recalls Popular Heartburn Drug Ranitidine: What You Need to Know
Medication commonly used to treat acid reflux and GERD pulled from the market after scientists find concerning levels of a potential cancer-causing substance in the drug. In April, the U.S. Food and Drug Administration (FDA) requested that all medications containing ranitidine be pulled from the market after an ongoing investigation…...
Understanding the Role of Physical Traits of Cancer on Tumor Growth
To better understand tumor initiation and growth, National Foundation for Cancer Research (NFCR) Fellow Dr. Rakesh Jain and colleagues continue to investigate the role of the physical microenvironment surrounding cancer cells. When a tumor is growing, the tissues that surround the tumor are disrupted physically and biochemically. The outcomes of…...
Strategic Media Partner
